MelanieHoppersMD

Medicine/Pediatrics • Jackson, TN

CMO of Physicians Quality Care

Join to view full profile

Dr. Hoppers is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hoppers' full profile

Already have an account?

Office
2075 Pleasant Plains Extended
Jackson, TN 38305
Phone+1 731-984-8400

Fax+1 731-984-8305

Education & Training

University of TennesseeResidency, Internal Medicine/Pediatrics, 1993 - 1997
University of Tennessee Health Science Center College of MedicineClass of 1993

Certifications & Licensure

CA State Medical License 2024 - 2026
UT State Medical License 2024 - 2026
CO State Medical License 2024 - 2025
TN State Medical License 1994 - 2025
MA State Medical License 2024 - 2024
American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012

Clinical Trials

Comparing the Efficacy, Safety, and Tolerability of Combination Antivirals (Amantadine, Ribavirin, Oseltamivir) Versus Oseltamivir for the Treatment of Influenza in Adults at Risk for Complications Start of enrollment: 2010 Sep 01
Completed
Phase 2
Safety and Efficacy Study of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza Start of enrollment: 2013 Mar 01
Completed
Phase 3
Phase 3 Efficacy and Safety Study of Favipiravir for Treatment of Uncomplicated Influenza in Adults - T705US316 Start of enrollment: 2014 Jan 01
Completed
Phase 3
Bucillamine for the Treatment of Acute Gout Flare in Subjects With Moderate to Severe Gout Start of enrollment: 2015 Apr 01
Completed
Phase 2
Long Term Safety and Efficacy Study of Tanezumab in Subjects With Osteoarthritis of the Hip or Knee Start of enrollment: 2015 Jul 21
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

42 citations
A Rapid, High-Sensitivity SARS-CoV-2 Nucleocapsid Immunoassay to Aid Diagnosis of Acute COVID-19 at the Point of Care: A Clinical Performance Study.
Paul K. Drain, Madhavi Ampajwala, Christopher Chappel, Andre B. Gvozden, Melanie Hoppers
Infectious Diseases and Therapy. 2021-02-24
172 citations
Effect of nitazoxanide in adults and adolescents with acute uncomplicated influenza: a double-blind, randomised, placebo-controlled, phase 2b/3 trial
Jason Haffizulla, Aaron Hartman, Melanie Hoppers, Harvey Resnick, Steve Samudrala
The Lancet. Infectious Diseases. 2014-07-01
12 citations
Performance of the LumiraDx Microfluidic Immunofluorescence Point-of-Care SARS-CoV-2 Antigen Test in Asymptomatic Adults and Children.
Paul K. Drain, Raed Sulaiman, Melanie Hoppers, Nigel M Lindner, Vicki Lawson
American Journal of Clinical Pathology. 2021-10-20

Journal Articles

Effect of nitazoxanide in adults and adolescents with acute uncomplicated influenza: a double-blind, randomised, placebo-controlled, phase 2b/3 trial
MD, Melanie Hoppers, MD, Harvey Resnick, MD, Steve Samudrala, MD, Christine Ginocchio, PhD, Matthew Bardin, PharmD, Prof Jean-François Rossignol, MDcorrespondenceemail..., Lancet Infectious Disease

Press Mentions

For People with Severe Long COVID, Medical Care Is Out of ReachSeptember 20th, 2024
Santa Clara County Holds Special Hearing on Long COVID and Chronic Fatigue SyndromeSeptember 3rd, 2024
Long Covid Affects Millions of AmericansJune 28th, 2024